Dispensaries are recommending cannabis for pain and sleep — with no evidence, UCSF study finds

The work of SSRI cofund Louisa Holmes, associate professor of geography & demography, was recently featured in this article published in the San Francisco Chronicle. By Catherine Ho, Staff Writer, for the San Francisco Chronicle Cannabis dispensaries in the Bay Area often recommend…

Q&A: What would reclassifying marijuana mean for medical research?

UNIVERSITY PARK, Pa. — There may be a major change in national drug policy coming soon. The Trump administration is considering reclassifying marijuana from a Schedule I to a Schedule III substance. The change in classification was proposed in 2024 under the Biden administration, following a…